Cambridge Investment Research Advisors’s Genworth Financial GNW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$393K Buy
41,484
+743
+2% +$6.61K ﹤0.01% 3189
2026
Q1
$331K Sell
40,741
-450
-1% -$3.82K ﹤0.01% 3192
2025
Q4
$372K Sell
41,191
-122,477
-75% -$1.07M ﹤0.01% 2992
2025
Q3
$1.46M Buy
163,668
+124,320
+316% +$1.03M ﹤0.01% 1755
2025
Q2
$306K Buy
39,348
+8
+0% +$56 ﹤0.01% 2960
2025
Q1
$279K Sell
39,340
-4,172
-10% -$29K ﹤0.01% 2920
2024
Q4
$304K Buy
43,512
+2,045
+5% +$14.7K ﹤0.01% 2820
2024
Q3
$284K Hold
41,467
﹤0.01% 2873
2024
Q2
$250K Sell
41,467
-300
-0.7% -$1.87K ﹤0.01% 2848
2024
Q1
$269K Sell
41,767
-89
-0.2% -$557 ﹤0.01% 2794
2023
Q4
$280K Buy
41,856
+2,589
+7% +$15.7K ﹤0.01% 2647
2023
Q3
$230K Hold
39,267
﹤0.01% 2703
2023
Q2
$196K Sell
39,267
-3,442
-8% -$18.8K ﹤0.01% 2885
2023
Q1
$214K Sell
42,709
-12,747
-23% -$70.6K ﹤0.01% 2766
2022
Q4
$293K Sell
55,456
-7,800
-12% -$36.7K ﹤0.01% 2451
2022
Q3
$221K Sell
63,256
-2,175
-3% -$8.78K ﹤0.01% 2620
2022
Q2
$231K Hold
65,431
﹤0.01% 2596
2022
Q1
$247K Sell
65,431
-3,475
-5% -$13.9K ﹤0.01% 2703
2021
Q4
$279K Sell
68,906
-200
-0.3% -$831 ﹤0.01% 2589
2021
Q3
$259K Sell
69,106
-24,656
-26% -$87.8K ﹤0.01% 2581
2021
Q2
$366K Sell
93,762
-30,722
-25% -$123K ﹤0.01% 2315
2021
Q1
$413K Buy
124,484
+3,075
+3% +$10.1K ﹤0.01% 2028
2020
Q4
$459K Hold
121,409
﹤0.01% 1825
2020
Q3
$407K Buy
121,409
+11,085
+10% +$29.5K ﹤0.01% 1737
2020
Q2
$255K Sell
110,324
-9,978
-8% -$31.4K ﹤0.01% 2013
2020
Q1
$399K Buy
120,302
+3,850
+3% +$16K ﹤0.01% 1508
2019
Q4
$512K Buy
116,452
+18,535
+19% +$77.9K ﹤0.01% 1565
2019
Q3
$431K Sell
97,917
-9,797
-9% -$40.9K ﹤0.01% 1605
2019
Q2
$400K Buy
107,714
+29,645
+38% +$105K ﹤0.01% 1576
2019
Q1
$299K Buy
78,069
+795
+1% +$3.48K ﹤0.01% 1806
2018
Q4
$360K Sell
77,274
-2,151
-3% -$9.29K ﹤0.01% 1532
2018
Q3
$331K Buy
79,425
+4,757
+6% +$21.5K ﹤0.01% 1729
2018
Q2
$336K Sell
74,668
-26,674
-26% -$92K ﹤0.01% 1644
2018
Q1
$287K Sell
101,342
-673
-0.7% -$2.02K ﹤0.01% 1706
2017
Q4
$317K Buy
102,015
+22,307
+28% +$77.1K ﹤0.01% 1620
2017
Q3
$307K Buy
79,708
+3,042
+4% +$10.9K ﹤0.01% 1534
2017
Q2
$289K Sell
76,666
-23,120
-23% -$87.6K ﹤0.01% 1529
2017
Q1
$411K Buy
99,786
+14,980
+18% +$57.7K 0.01% 1173
2016
Q4
$323K Sell
84,806
-8,792
-9% -$38.7K 0.01% 1232
2016
Q3
$464K Buy
93,598
+8,025
+9% +$30.8K 0.01% 1079
2016
Q2
$221K Buy
85,573
+26,944
+46% +$87.1K ﹤0.01% 1332
2016
Q1
$160K Buy
58,629
+6,840
+13% +$17.3K ﹤0.01% 1441
2015
Q4
$193K Buy
51,789
+16,458
+47% +$76.2K ﹤0.01% 1384
2015
Q3
$163K Buy
35,331
+10,357
+41% +$61K ﹤0.01% 1299
2015
Q2
$189K Sell
24,974
-1,258
-5% -$10K 0.01% 1292
2015
Q1
$192K Buy
26,232
+11,143
+74% +$84.8K 0.01% 1264
2014
Q4
$128K Buy
+15,089
New +$158K ﹤0.01% 1279

Other funds holding GNW

Cambridge Investment Research Advisors's GNW Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its Genworth Financial (GNW) stake by 1.8% in Q2 2026, buying an estimated $6.61K and bringing the position to 41,484 shares worth $393K. The position accounts for ﹤0.01% of the portfolio, ranked #3189.

Cambridge Investment Research Advisors first reported a position in GNW in Q4 2014 and has held it in 47 quarters since. The position peaked at $1.46M in Q3 2025. 368 funds tracked by Wall St. Rank hold GNW as of Q2 2026.

  • Cambridge Investment Research Advisors held 41,484 shares of Genworth Financial worth $393K as of Q2 2026.
  • Cambridge Investment Research Advisors bought 743 Genworth Financial shares in Q2 2026, an estimated $6.61K.
  • Genworth Financial made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #3189 holding.
  • Cambridge Investment Research Advisors first reported a position in Genworth Financial in Q4 2014 and has held it in 47 quarters since.
  • Cambridge Investment Research Advisors's Genworth Financial position peaked at $1.46M in Q3 2025.
  • 368 funds tracked by Wall St. Rank held Genworth Financial as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.